Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
236.70%
Change (1 year)
Categories
Viking Therapeutics (VKTX) - P/B ratio
P/B ratio as of May 2024 : 9.09
According to Viking Therapeutics
's latest financial reports the company has a price-to-book ratio of 9.09.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Viking Therapeutics - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 5.34 | 7.71% |
| 2022-12-31 | 4.96 | 178.27% |
| 2021-12-31 | 1.78 | 5.67% |
| 2020-12-31 | 1.69 | -19.5% |
| 2019-12-31 | 2.10 | 13.7% |
| 2018-12-31 | 1.84 | -82.42% |
| 2017-12-31 | 10.5 | 251.39% |
| 2016-12-31 | 2.98 | -21.15% |
| 2015-12-31 | 3.78 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | 12.9 | 41.99% | 🇺🇸 USA |
 Repligen
RGEN | 4.74 | -47.90% | 🇺🇸 USA |